Skip to Content

CNN – Health

Two people who received Pfizer's respiratory syncytial virus vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome

Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says

By Janelle Chavez, CNN Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration has asked Pfizer to conduct a safety study if the shot is approved, according to agency documents released Friday. The cases were confirmed in

Continue Reading
Two people who received Pfizer's respiratory syncytial virus vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome

Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says

By Janelle Chavez, CNN Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration has asked Pfizer to conduct a safety study if the shot is approved, according to agency documents released Friday. The cases were confirmed in

Continue Reading
Skip to content